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With emerging knowledge regarding the pathogenesis involving SARS-CoV-2, it is becoming apparent 
that no tissue is spared in the body. Ferrandi et al (5) suggested a cause for myopathy in COVID-19 
via the ACE2 expression that leads to myocytes becoming susceptible to SARS-CoV-2. We would like 
to add that, the muscle involvement in COVID-19 is likely to be early in the infection. We have 
recently explored the muscles in rheumatoid arthritis (RA) (4) using quantitative MRI measures, 
which reflect physiological changes regarded as an indirect measure of muscle inflammation (3). 
These abnormal muscle changes which are present in established RA patients, are also noticeable in 
newly diagnosed untreated RA patients. This suggests that muscle is likely to be sensitive to the 
inflammatory process and is involved early. COVID-19 also involves multiple pro-inflammatory 
cytokines; the muscles may already be affected in susceptible patients at the time of diagnosis, 
which may then lead to various muscle related pathologies including affecting the respiratory 
muscles as eluded to by Ferrandi et al. Further, Ferrandi et al highlighted that the aging population 
are at increased risk of COVID-19; we showed that there are age-related muscle changes on MRI that 
correlates with frailty and muscle function (2). Our RA patients, when treated to arthritis remission, 
continued to have persistent abnormal MRI changes and weaker muscles. This is analogous to 
patients who ‘recovered’ from COVID-19, but continue to manifest various muscular symptoms (1). 
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